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Abstract 
Purpose: The present study addressed two questions related to macronutrient supplementation 
during endurance exercise. Firstly, the effects of carbohydrate and protein co-ingestion on time 
trial (TT) performance were compared to carbohydrate alone. Secondly, the effects of isolated 
protein ingestion on TT performance were compared to a placebo.    
Methods: Six trained cyclists (Age: 22 ± 1 years; Height: 167 ± 12 cm; Weight: 60 ± 10 kg; 
VO2max: 62 ± 7 ml/kg/min) completed four experimental trials, consisting of constant-load cycling 
for two hours (55% Wmax) immediately followed by a 30-km simulated time trial. During the trials, 
subjects consumed one of four experimental beverages at regular intervals during exercise: a non-
caloric placebo (PL), a protein-only beverage (PR: 15 g/hr), a carbohydrate-only beverage (45 
g/hr), or a carbohydrate and protein beverage (CP: 45 g/hr CHO + 15 g/hr PRO). Physiological 
measurements (VO2, VE, HR, RER, blood glucose, and blood lactate) and subjective 
measurements (GI distress and RPE) were assessed throughout both the constant-load and TT 
exercise phases. Trials were completed in a randomly-counterbalanced order. Mean ± 90% 
confidence intervals were calculated for all measures, and magnitude-based qualitative inferences 
were used to assess treatment effects.  
Results: In comparison to PL (62.8 ± 8.1 min), both CHO and CP provided ‘possible’ benefits in 
TT performance (58.9 ± 6.5 min; 59.2 ± 9.4 min respectively) while no clear effects of PRO on 
performance were observed (61.0 ± 8.0 min). Furthermore, CP had no clear effect on performance 
versus CHO.  
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Conclusions: In our sample, the addition of protein to a moderate-dose of carbohydrate did not 
result in meaningful improvements in time trial performance versus carbohydrate alone. Similarly, 
protein consumption alone provided no ergogenic effects versus a placebo.  
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Chapter I: Introduction 
In the world of competitive sports, the smallest improvements in performance can make 
the difference between making a team or being cut; making a diving catch or coming up short, or 
even the difference between winning and losing a championship. Nutrition has long been a 
variable that athletes manipulate in an effort to maximize performance. For example, numerous 
studies have reported that carbohydrate ingestion during exercise improves endurance 
performance through mechanisms relating to overall energy supply and manipulation of the 
central nervous system (15). It has been found that blood glucose is a key source of energy 
during prolonged exercise (15). With the intake of supplemental carbohydrates, liver and muscle 
glycogen stores may be spared, and high rates of carbohydrate oxidation can be maintained for 
longer durations during exercise (15). Additionally, supplemental carbohydrate ingestion during 
exercise has been found to provide benefits via the central nervous system, and rinsing the mouth 
with carbohydrate solutions (even without ingestion) may also, improve endurance performance 
(15).  
The concept of supplementing carbohydrates and fluids during exercise began in 1965 at 
the University of Florida in an attempt to improve the Gator’s on-field performance (5). It was 
discovered that providing the athletes with a solution rich in carbohydrates and electrolytes 
helped the athletes perform at a higher level (5). The beneficial effects of carbohydrate sports 
beverages on metabolism and performance is strongly supported in the scientific studies from the 
past 35 years (5). As a result, carbohydrate-electrolyte sports beverages are used ubiquitously 
among modern endurance athletes.  
 10 
More recently, the potential ergogenic effects of supplemental protein in sports beverages 
has been investigated.  In 2003, Ivy and colleagues reported that the co-ingestion of carbohydrate 
and protein (CHO+P) during exercise significantly prolonged time to fatigue during cycling 
exercise versus a carbohydrate-only beverage (9). Saunders and colleagues reported similar 
findings in a study conducted in 2004 (14). These initial studies indicated that the addition of 
protein to a carbohydrate supplement provided additional performance benefits over 
carbohydrates alone. However, the generalizability of these findings were limited by two issues.  
Firstly, both studies used Time-to-Exhaustion (TTE) exercise protocols which required subjects 
to cycle at a specified intensity, for as long as possible. Although an important outcome, 
improvements in TTE are not directly applicable to athletic performance, as cycling events are 
generally performed with the goal of completing a fixed distance in the fastest time possible. A 
second limitation of the aforementioned studies relates to the concentrations of carbohydrate 
(CHO) and protein (PRO) in the experimental beverages. Both studies compared CHO+P 
beverages versus CHO beverages that were matched for carbohydrate content. As a result, the 
CHO+P beverages contained additional calories, and it could not be determined if the observed 
improvements in performance were due to a unique benefit from protein per se.  
Numerous studies have subsequently been conducted to determine the effects of CHO+P 
beverages on endurance performance.  The topic remains controversial, and generalizations are 
difficult due to the wide variety of exercise protocols and beverage comparisons among these 
studies.  However, beverage composition has an important influence on performance outcomes, 
and a better understanding of the literature can be obtained by examining the existing studies 
based on the type of experimental beverages examined in each study, as discussed below. 
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One group of CHO+P studies have used experimental beverages that were matched for 
carbohydrate content, with total carbohydrate intake below maximal gastrointestinal uptake rates 
(and, thus, below the rates theorized to produce optimal ergogenic effects with carbohydrates). 
Specifically, all studies in this group used experimental beverages ingested at rates below 50 
gCHO•hr-1. In 2003, in a study by Ivy, three experimental beverages were used in a time-to-
exhaustion exercise protocol (9). Experimental beverages consisted of placebo, a 7.75% 
carbohydrate solution (CHO), and a 7.75% carbohydrate + 1.94% protein solution (CHO+P). 
The researchers observed that the addition of protein to the carbohydrate supplement improved 
time-to-exhaustion versus the placebo and CHO beverages (9). In 2004, Saunders and colleagues 
compared the effects of a 7.3% carbohydrate solution (CHO) versus a 7.3% carbohydrate and 
1.8% protein solution (CHO+P) (14). Similar to Ivy, the study by Saunders found that subjects 
consuming the CHO+P beverage exercised 29% longer at 75% VO2peak than those consuming the 
CHO beverage (14). Finally, in 2007, another study by Saunders used gels matched for 
carbohydrate content below the maximum absorption rate (16). The experimental gels consisted 
of a 0.15 g carbohydrate per kg of bodyweight solution (CHO) and a 0.15 g carbohydrate per kg 
of bodyweight + 0.038 g protein per kg bodyweight solution (CHO+P) (16). It was found that 
those subjects consuming the CHO+P gel rode 13% longer at 75% VO2peak on a cycle ergometer 
than those that consumed the CHO gel (16). Based on these studies it appears that the addition of 
protein to carbohydrate sports beverages can elicit significant improvements in TTE versus CHO 
beverages, when the carbohydrate content of the beverages is below the maximal absorption rate. 
However, no published studies to date have compared the effects of carbohydrate-matched 
beverages on time trial performance, so the effects of CHO+P on endurance ‘performance’ under 
these conditions cannot be quantified. 
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Following the publication of the aforementioned studies by Ivy and Saunders, subsequent 
studies examined whether the addition of protein could enhance the efficacy of carbohydrate 
beverages consumed at maximal gastrointestinal uptake rates (i.e. at rates believed to optimize 
the ergogenic effects of CHO intake). Specifically, the studies in this group used experimental 
beverages that containing greater than 60 gCHO•hr-1. In 2009, a study by Saunders used 
experimental beverages consisting of 6% carbohydrates (CHO) and 6% carbohydrates and 1.8 
grams of protein hydrolysate (CHO+P) (17). It was found that late-exercise time trial 
performance was enhanced by a small, but significant, degree (~30 s over the final 5 km) with 
consumption of the CHO+P beverage compared to consumption of the CHO beverage (17). In 
contrast, other studies in this group observed no beneficial effects of supplemental protein. For 
example, Van Essen and colleagues (2006) used experimental beverages with 6% carbohydrates 
(CHO), with an additional 2% protein (in the CHO+P beverage) (21). Van Essen observed no 
differences in performance between beverages (21). In 2010, Breen and colleagues used similar 
beverages with a time-trial exercise protocol. Experimental beverages consisted of 65 gCHO•hr-
1 (CHO) plus an additional 19 gPRO•hr-1 (CHO+P) (1). Breen found that the CHO+P beverage 
did not improve late-exercise performance versus the CHO beverage (1). Lastly, in 2008, a study 
by Valentine compared two different carbohydrate-only beverages in addition to a carbohydrate 
plus protein beverage (20). Experimental beverages consisted of a placebo (PLA), a 7.75% 
carbohydrate solution (CHO), a 9.69% carbohydrate solution (CHO+CHO), and a 7.75% 
carbohydrate solution with an additional 1.94% protein solution (CHO+P) (20). In this study, 
CHO and CHO+P were matched for carbohydrate content while CHO+CHO and CHO+P are 
matched for caloric content. No significant differences in time-to-exhaustion were observed 
between CHO+P, CHO or CHO+CHO beverages, although all three experimental beverages 
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improved performance over the placebo (20). This group of studies has collectively shown that 
adding protein to carbohydrate beverages consumed at maximal gastrointestinal absorption rates 
of carbohydrates, appears to have little to no effect on improving endurance performance.  
Researchers have also examined whether CHO+P beverages influence performance 
versus carbohydrate beverages that are matched for total calories. In 2006, Romano-Ely and 
colleagues used experimental beverages with 9.3% carbohydrates (CHO) and another with 7.5% 
carbohydrates with an additional 1.9% protein (CHO+P) (13). Subjects cycled at 70% VO2peak 
until fatigue under each experimental condition. No differences in TTE were observed between 
CHO and CHO+P (13). In 2008, Valentine and colleagues found similar results during a study in 
which two different carbohydrate-only beverages were compared in addition to a carbohydrate 
plus protein beverages (as previously discussed) (20). The results of Valentine’s study have 
indicated that the isocaloric beverages, CHO+CHO and CHO+P were not significantly different 
in time to exhaustion at the 75% VO2peak intensity (20). Together, the studies by Romano-Ely 
and Valentine have indicated that CHO+P beverages do not improve endurance performance 
versus carbohydrate beverages matched for total calories. However, these studies also 
demonstrate that some carbohydrates can be replaced with protein without adversely affecting 
endurance performance. 
A final group of studies has used beverages not matched for carbohydrate content or 
calories. These studies are harder to interpret, as potential differences in performance between 
treatments cannot be attributed to differences in individual macronutrients and/or calories. 
Nevertheless, McCleave and colleagues (2011) investigated the effects of a CHO+P beverage 
containing 3% carbohydrates and 1.2% protein, versus a CHO beverage containing 6% 
carbohydrates (11). Subjects completed a protocol consisting of 3 hours of varied-intensity 
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cycling following immediately by a ride to exhaustion at ~75% VO2max. TTE was significantly 
greater with consumption of CHO+P compared to CHO (20). In 2010, a study by Martinez-
Lagunas and colleagues used three beverages, none of which were matched for carbohydrate or 
caloric content (10). Beverage CHO+PRO H contained 4.5% carbohydrates and 1.15% protein, 
beverage CHO+PRO L contained 3% carbohydrates and 0.75% protein, and beverage CHO 
contained 6% carbohydrates. Subjects cycled at intensities between 55% and 75% VO2max for 2.5 
hours before completing a ride at 80% VO2max until fatigue. No significant differences in TTE 
were found between CHO, CHO+PRO H, or CHO+PRO L (10). Similar to the aforementioned 
findings from McCleave and colleagues, Martinez-Lagunas showed that a beverage (CHO+PRO 
L) lacking in carbohydrate content, protein content, and total calories was able to elicit similar to 
results to the beverages containing more macronutrients. A final study, by Schroer and 
colleagues (2014), examined the effects of protein intake (without carbohydrate co-ingestion) on 
performance. The study compared three different treatment beverages: a placebo (PLA), a 
beverage containing 45 g/L protein (PRO), and a beverage containing 15 g/L alanine an amino 
acid present in protein, which has been speculated to have possible influences on performance 
(18). Subjects performed 120 minutes of cycling at 55% Wmax before completing a 30 km time 
trial. Both ALA and PRO beverages ‘possibly’ harmed time trial performance compared to PLA 
(18). The results of this study (as well as those from the aforementioned investigations in this 
section) suggest that the previously published improvements in performance with CHO+P co-
ingestion are not the simple result of additional calories from protein. Instead, it is possible that 
protein may be impacting endurance performance via another mechanism, such as a protein-
specific synergistic influence on the ingested carbohydrate. However, it should be noted that the 
protein intake rates in the Schroer study (45 g/hr whole protein) greatly exceeded the amounts of 
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protein co-ingested with CHO in studies that have reported performance benefits with CHO+P 
(typically 10-20 g/hr), which likely contributed to the possible detriments in performance versus 
CHO. It is not currently known whether protein ingestion at these lower rates has any impact on 
endurance performance.  
In summary, at least three studies have reported that CHO+P ingestion at moderate intake 
rates (< 50 gCHO/hr) results in substantial improvements (13-36%) in TTE versus CHO 
beverages containing equal carbohydrate content (9, 14, 16). Additional calories in the CHO+P 
beverages of these studies (due to the supplemental protein) have been cited as a criticism of 
these investigations.  However, there is no evidence to date that the ingestion of protein alone has 
any impact on endurance performance and one recent study reported that relatively high protein 
intake during exercise may actually impair performance.  Thus, it is possible that CHO+P 
ingestion may be impacting endurance performance via another mechanism, such as a protein-
specific synergistic influence on the ingested carbohydrate.   
A number of studies have reported that CHO+P ingestion has no influence on endurance 
performance in cycling time trials (1, 12, 21), which represent athletic performance more closely 
than TTE protocols.  However, each of these studies utilized beverages consumed at very high 
rates of CHO ingestion (> 60 gCHO/hr), in which additional macronutrient intake has little or no 
impact on performance.  As a result, it remains unknown whether CHO+P ingestion at moderate 
intake rates (< 50 gCHO/hr) results in meaningful improvements in cycling performance, in 
addition to TTE.    
As illustrated above, there are numerous unanswered questions regarding the influences 
of CHO+P ingestion on endurance performance.  Specifically, it remains to be determined how 
varying amounts of carbohydrate and protein intake (alone, and co-ingested) influence 
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performance during prolonged cycling time trials.  Our laboratory is currently conducting a study 
investigating two questions on this topic: 
1) Does CHO+P ingestion (at 45 gCHO/hr + 15 gPRO/hr) improve cycling performance 
versus a CHO beverage matched for carbohydrate content (45 gCHO/hr)?  
2) Does the ingestion of 15g/hr of protein ingestion improve cycling performance versus 
a placebo (PL)? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 17 
Chapter II: Methodology 
Participants 
Study participants were recruited and selected based on three primary criteria. First, all 
subjects were required to be between 18 and 45 years of age. Secondly, each subject, following 
their VO2peak measurement, was required to have a VO2peak greater than 55 ml/kg/min or 4.5 
L/min. Finally, each selected subject was characterized as “low risk” for exercise complications 
using criteria from the American College of Sports Medicine’s Guidelines for Exercise Testing 
and Prescription (9th Ed., ACSM, 2014). 
Twelve subjects were recruited for the current study and based on their completion of the 
criteria mentioned previously. Of the twelve recruited subjects, five (3 males and 2 females) 
completed all experimental trials while the final subject completed only three experimental trials 
(Age: 22 ± 1 years; Height: 167 ± 12 cm; Weight: 60 ± 10 kg; VO2max: 62 ± 7 ml/kg/min). 
Study Design 
Selected subjects completed a total of six trials, each of which being separated by 5-7 
days. Specifically, the following trials were completed: 1 pre-testing trial, 1 familiarization trial, 
and 4 trials containing experimental treatments. With each experimental trial, subjects consumed 
one of the following four beverages. Subject either received a non-caloric placebo (PLA), a 
protein-only beverage (15 g/hr – PRO - whey), a carbohydrate-only beverage (45 g/hr – CHO - 
dextrose), or a combination of carbohydrate and protein (45 g/hr CHO + 15 g/hr PRO – CP), all 
of which were matched for flavor.  
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Experimental Trial Design 
Subjects completed four experimental trials using an electronically braked cycle 
ergometer. Two exercise phases were completed within each trial. The first phase consisted of 
120 minutes of steady-state cycling at 55% Wmax. The second phase of the exercise protocol 
consisted of a simulated 30-km time trial (~50 minutes).  
Experimental Treatments 
Treatments were supplied to subjects using a randomly counterbalanced, double-blinded, 
placebo design. Beverages were provided to subjects before the exercise protocol began, 
throughout the steady-state exercise phase, and throughout the time trial. Prior to exercise, 
subjects received a bolus dose (600 ml) of their specific beverage. During the steady-state 
exercise phase, subjects received 150 ml every 15 minutes. Finally, during the time trial, subjects 
received 150 ml at three specific distance points, those being 7.5 km, 15 km, and 22.5 km. Each 
beverage was consumed within two minutes during exercise.  
Dietary and Exercise Controls 
Subjects were given a “food log” to record all dietary intake 24 hours prior to their first 
experimental trial. The subject was told to replicate this dietary intake prior to each experimental 
trial thereafter. Dietary logs were then obtained following each experimental trial.  
Subjects were told to refrain from any form of heavy exercise 48 hours prior to each 
experimental trial. Additionally, subjects were asked to record all physical activity 72 hours 
preceding each experimental trial. All subjects were asked to continue exercise habits throughout 
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the duration of the study with consideration towards the final 48 hours prior to each experimental 
trial.  
Subjects performed each experimental trial being fed prior to the initiation of exercise. 
Standardized meals were given to each subject 1-2 days prior to each trial. The night before each 
trial, subjects consumed a liquid meal replacement (Ensure Shakes). Two hours prior to the 
experimental trials, subjects then consumed a standardized meal of ~500 kcals.  
Measurements 
Performance Time and Mean Power Output: were used to measure exercise performance, 
measured during phase 2. 
Metabolic Measurements: A Moxus Modular Metabolic System recorded metabolic 
measurements at the following times during exercise: minutes 15, 35, 55, 75, 95, and 115 of 
phase 1, and at 20 km and 30 km of phase 2. 
Blood Glucose and Lactic Acid: finger stick blood samples were obtained at the following times: 
minutes 20, 40, 60, 80, 100, and 120 of phase 1, and at 20 km and 30 km of phase 2. Glucose and 
lactate levels was determined using an automated analyzer. 
Heart Rate: was assessed at the same times as blood glucose and lactic acid using a heart rate 
monitor. Average heart rate of the 30 km time trial was also recorded.  
Ratings of Perceived Exertion (RPE): subjective ratings of exertion was collected using a Borg 
RPE scale measured 6-20. Measurements were obtained at the times mentioned for blood 
glucose and lactic acid.  
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Gastrointestinal Distress Scale: subjects were asked to complete a questionnaire at minutes 30, 
60, 90, and 120 of phase 1, and at 20 km and 30 km of phase 2. The questionnaire contains 
questions regarding the presence of the following GI problems: stomach problems, GI cramping, 
bloated feeling, diarrhea, nausea, dizziness, headache, belching, vomiting, and urge to urinate or 
defecate. The items were then scored on a 10-point scale (1 = not at all, 10 = very, very much). 
Data Analysis 
 Probabilistic magnitude-based inferences, using methods described by Hopkins and 
colleagues, were used to analyze collected data for the present study (7). Many recently 
published studies have utilized this method of analysis, especially those investigating the effects 
of nutritional supplementation on endurance performance. This approach has several advantages 
over null-hypothesis testing as the Hopkins method uses effect-magnitudes, estimate precision, 
and interpretive descriptors in order to qualify the probability of an important experimental 
effect. The present study maintained a 90% confidence interval to illustrate uncertainty within 
treatment effects, as this confidence interval represents an ‘unclear’ effect with a >5% chance of 
being either negative or positive (7). Additionally, threshold values indicating a substantial 
change were calculated as 0.2 x SD (Standard Deviation), from the placebo trial. A spreadsheet 
(6), developed by Hopkins and colleagues was utilized in order to classify treatment effects as 
either beneficial (positive), harmful (negative), or trivial (negligible) (5). The following 
qualitative inferences were used to describe the likelihoods of reaching substantial change 
threshold values: <1%: most unlikely, 1-5%: very unlikely, 5-25%: unlikely, 25-75%: possible, 
75-95%: likely, 95-99%: very likely, and >99%: most likely. An ‘unclear’ inference was applied 
to measurements that contained values within the 90% CI that exceeded threshold for both 
positive and negative effects.  
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Chapter III: Results 
30-km Time Trial Performance 
Mean performance times, power outputs, and qualitative inferences for comparisons between 
treatments are summarized in Figure 1, Figure 2, and Figure 3. Most notably, both CHO and 
CHO+PRO were shown to have ‘possible benefits’ over PL (-3.9 ± 5.0% and -3.6 ± 5.4% 
respectively). No clear effects were observed between other treatments. 
 
 
Figure 1. Mean time trial performance measurements (in minutes) for each experimental 
beverage. Y-axis error bars represent one standard deviation of the mean. 
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Physiological Measurements during Constant-Load Cycling 
Measured values of VO2, RER, blood glucose and lactate, and RPE (and qualitative inferences 
for between-treatment differences) during the constant-load phase are summarized in Table 2. 
Differences in steady-state responses between treatments were generally ‘unclear’, or small in 
magnitude. The most consistent observation was that blood glucose levels tended to be slightly 
higher in the trials containing carbohydrate (CHO and CP) versus other trials (PL and PRO). 
 
Physiological Measurements during the Time-Trial 
Physiological measurements obtained during the time trial are summarized, in addition to 
qualitative inferences, in Table 3. Although there were some ‘unclear’ comparisons between 
individual treatments, VO2, RER, blood glucose and lactate levels tended to be generally higher 
in the CHO and CP trials versus the PL and PRO trials, which was likely a reflection of the 
higher power outputs during the CHO and CP trials. RPE was similar across treatments.
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Figure 2. Comparison of mean time trial performance between experimental treatments. 
Treatment effects (mean difference ± 90% CI) for each experimental beverage is compared to the 
placebo. Open circles represent the mean value while the vertical lines represent the range of 
individual values.  
Probabilities of benefit/trivial/harm and Qualitative Inferences:  
CHO-PL: ‘possible’ benefit (4/23/72) for CHO; PRO-PL: ‘unclear’ (10/48/92); CP-PL: 
‘possible’ benefit (2/30/68) for CHO.  
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Figure 3. Comparison of mean time trial performance between experimental treatments. 
Treatment effects (mean difference ± 90% CI) for each experimental beverage is compared to the 
carbohydrate-only beverage. Open circles represent the mean value while the vertical lines 
represent the range of individual values. 
Qualitative Inferences: 
PRO-CHO: ‘unclear’ (51/36/13); CP-CHO: ‘unclear’ (39/36/25). 
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Table 1. Constant Load Measurements. 
 
Variable 
 
Time 
Mean ± SD Treatment Differences 
PL CHO PRO CP CHO-PL PRO-PL CP-PL PRO-CHO CP-CHO 
VO2 
(ml·min-1) 
20 
2548  
± 515 
2491  
± 459 
2455  
± 424 
2506  
± 518 
-58 ± 120 
3/70/27 
Possible 
14 ± 148 
14/80/6 
Unclear 
-43 ± 115 
4/65/31 
Possible  
77 ± 35 
16/84/0 
Likely Trivial  
15 ± 77 
5/89/6 
Likely Trivial 
120 
2681 
± 509 
2591  
± 484 
2624  
± 564 
2639  
± 542 
-89 ± 128 
3/44/53 
Possible 
61 ± 117 
22/75/3 
Likely Trivial 
-41 ± 158 
7/52/41 
Unclear 
166 ± 182 
76/23/1 
Likely  
48 ± 92 
13/83/4 
Likely Trivial 
RER 
20 
0.90  
± 0.02 
0.88  
± 0.01 
0.89  
± 0.01 
0.91  
± 0.03 
-0.02 ± 0.02 
3/3/94 
Likely 
-0.02 ± 0.01 
1/3/96 
Very Likely  
0.00 ± 0.02 
33/29/38 
Unclear 
0.01 ± 0.02 
75/17/8 
Unclear 
0.03 ± 0.02 
88/5/6 
Unclear 
120 
0.85  
± 0.03 
0.86  
± 0.01 
0.85  
± 0.03 
0.88  
± 0.03 
0.01 ± 0.02 
61/30/9 
Unclear 
-0.01 ± 0.01 
2/53/45 
Possible  
0.02 ± 0.02 
90/7/3 
Likely  
-0.01 ± 0.02 
5/17/78 
Likely  
0.02 ± 0.02 
74/19/7 
Unclear 
Glucose 
(mg·dL-1) 
20 76 ± 11 80 ± 9  74 ± 5 81 ± 7  
-4 ± 9 
51/29/20 
Unclear 
-5 ± 10 
11/22/67 
Unclear 
5 ± 10 
42/37/21 
Unclear 
-7 ± 5 
1/4/95 
Likely  
1 ± 5 
13/55/31 
Unclear 
120 66 ± 7 75 ± 11 70 ± 5 75 ± 7 
9 ± 11 
80/8/12 
Unclear 
2 ± 4 
70/26/4 
Possible  
10 ± 7 
92/4/4 
Likely 
-6 ± 12 
15/12/73 
Unclear 
1 ± 6 
43/29/28 
Unclear 
Lactate 
(mmol·L-1) 
20 
1.9  
± 0.9 
1.9  
± 0.7 
1.5  
± 0.4 
1.5  
± 0.3 
0.0 ± 0.8 
45/23/32 
Unclear 
-0.6 ± 1.0 
11/12/77 
Unclear 
-0.4 ± 0.6 
5/13/82 
Unclear 
-0.6 ± 0.5 
2/5/92 
Likely  
-0.4 ± 0.6 
4/10/86 
Likely  
120 
1.4  
± 0.2 
1.6  
± 0.6 
1.7  
± 0.9 
1.5  
± 0.5 
0.2 ± 0.5 
84/6/10 
Unclear 
0.3 ± 0.7 
56/9/35 
Unclear 
0.1 ± 0.5 
42/9/49 
Unclear 
0.0 ± 1.0 
31/7/62 
Unclear 
-0.1 ± 0.5 
8/5/87 
Unclear 
RPE 
(6-20) 
20 
12.3  
± 1.0 
11.5  
± 1.4 
12.2  
± 0.8 
12.2  
± 1.2 
-0.8 ± 0.6 
3/7/90 
Likely 
-0.4 ± 0.9 
10/22/67 
Unclear 
-0.2 ± 0.6 
17/32/51 
Unclear 
0.4 ± 1.1 
66/19/15 
Unclear 
0.7 ± 0.8 
76/14/10 
Unclear 
120 
14.8  
± 1.9 
14.0  
± 1.1 
14.2  
± 0.8 
14.0  
± 1.1 
-0.8 ± 1.4 
11/55/34 
Unclear 
0.0 ± 1.2 
28/27/25 
Unclear 
-0.8 ± 1.2 
10/37/52 
Unclear 
0.2 ± 1.4 
42/38/21 
Unclear 
0.0 ± 1.0 
19/41/39 
Unclear 
*Note: One subject did not complete a PRO trial, so mean values (and corresponding treatment differences) were calculated on a 
sample of 5
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Table 2. Time Trial Measurements. 
Variable Mean ± SD Treatment Effects 
PL CHO PRO CP CHO-PL PRO-PL CP-PL PRO-CHO CP-CHO 
VO2 
(ml·min-1) 
2696  
± 686 
2729  
± 726 
2642  
± 626 
2959  
± 867 
34 ± 635 
4/26/70 
Possible 
-93 ± 287 
6/64/30 
Unclear 
264 ± 480 
14/77/10 
Unclear 
154 ± 241 
54/43/3 
Possible 
230 ± 309 
72/24/4 
Possible 
RER 
0.81  
± 0.06 
0.84  
± 0.02 
0.82  
± 0.03 
0.87  
± 0.05 
0.03 ± 0.04 
63/30/6 
Unclear 
-0.01 ± 0.03 
4/40/56 
Possible 
0.04 ± 0.01 
100/0/0 
Most Likely 
-0.03 ± 0.02 
1/5/94 
Likely 
0.03 ± 0.03 
69/24/7 
Unclear 
Glucose 
(mg·dL-1) 
63  
± 7 
76  
± 6 
66  
± 5 
73  
± 6 
12.4 ± 3.3 
100/0/0 
Most Likely 
0.0 ± 3.5 
21/59/20 
Unclear 
9.8 ± 6.6 
95/3/1 
Very Likely 
-11.1 ± 2.9 
0/0/100 
Most Likely 
-2.7 ± 4.5 
4/17/80 
Likely 
Lactate 
(mmol·L-1) 
1.5  
± 0.7 
2.0  
± 0.9 
1.2  
± 0.4 
1.7  
± 0.8 
0.5 ± 0.6 
64/26/10 
Unclear 
-0.4 ± 0.9 
13/15/72 
Unclear 
0.1 ± 0.6 
9/37/54 
Unclear 
-0.7 ± 1.2 
10/9/81 
Unclear 
-0.4 ± 0.6 
10/15/75 
Unclear 
RPE 
(6-20) 
17.0  
± 1.7 
16.7  
± 0.8 
16.2  
± 1.3 
16.8  
± 1.1 
-0.3 ± 0.8 
20/64/16 
Unclear 
-0.4 ± 0.5 
2/37/61 
Possible 
-0.2 ± 0.6 
19/65/16 
Unclear 
-0.4 ± 0.5 
2/33/65 
Possible 
0.2 ± 0.6 
18/62/20 
Unclear 
*Note: One subject did not complete a PRO trial, so mean values (and corresponding treatment 
differences) were calculated on a sample of 5. 
 
GI Distress Symptoms 
Ratings of GI discomfort were low across all treatments.  Mean values (1-10 scale) measured 
during the constant-load phase, and time-trial phase were ≤ 1.8 for all GI variables (stomach 
problems, GI cramping, bloating, nausea, belching, and vomiting).  No more than one subject per 
treatment reported a score >2 at any particular time-point, and these ratings appeared to be 
randomly distributed across treatments. No subject reported any GI symptoms greater than 5 
(moderate). 
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Chapter IV: Discussion 
A primary purpose of the present study was to determine if the co-ingestion of 
carbohydrate and protein during exercise enhanced cycling performance versus carbohydrate 
alone.  Performance in a 30 km time-trial (following 120 min at 55% Wmax) was ‘possibly’ 
improved by both CP (59.2 ± 9.4 min) and CHO (58.9 ± 6.5 min) versus a non-caloric placebo 
(62.8 ± 8.1 min), but no clear differences were observed between CP and CHO beverages. 
The observed improvement in cycling performance in our carbohydrate-containing 
beverages (CHO and CP) has been reported in numerous prior studies (9, 14, 16).  During 
prolonged endurance exercise, the ergogenic effects of carbohydrate are largely attributed to the 
maintenance of high rates of carbohydrate oxidation late in exercise (9, 12, 14, 16, 17, 20).  In 
support of this concept, we observed ‘likely’ elevations in steady-state RER and blood glucose 
with CP supplementation when compared to the placebo. Additionally, CP co-ingested resulted 
in ‘most likely’ and ‘very likely’ increases in time trial RER and blood glucose respectively, as 
compared with the placebo. 
Prior studies comparing the effects of CP and CHO on endurance performance have 
provided conflicting findings. Some studies have reported relatively large improvements in 
performance with CP (9, 14, 16), while others have shown no differences between CP and CHO 
beverages (1, 12, 20, 21).  Studies reporting no effects with CP have utilized beverages with high 
carbohydrate content (60+ g/hr) and typically used time-trial protocols, suggesting that the 
addition of protein may have little or no effects on time-trial performance when carbohydrate is 
consumed at rates that maximize exogenous oxidation rates (1, 12, 21).  The studies reporting 
large improvements with CP have typically compared beverages containing moderate 
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carbohydrate content (40-50 g/hr), and employed time-to-exhaustion protocols.  Because no prior 
studies have used a time-trial model to examine CP beverages containing moderate carbohydrate, 
it is unclear whether protein can elicit benefits under these conditions.  The current findings 
provides novel information in this respect, as no clear improvements in time-trial performance 
were observed with  CP (45 gCHO/hr + 15 gPro/hr) versus CHO (45 g/hr).  
It is not clear why CP with moderate carbohydrate could enhance time-to-exhaustion (9, 
14, 16), but not performance in a long-duration time trial, as shown in the present study.  
However, it is theoretically possible that the TTE protocol creates a more favorable environment 
for detecting possible ergogenic effects with CP. For example, some evidence suggests that 
carbohydrate and protein co-ingestion could shift carbohydrate usage towards exogenous blood 
glucose potentially delaying the use of endogenous glycogen stores, which could contribute to a 
delayed onset of fatigue (19). Similarly, there is indirect evidence that CP may impact endurance 
performance via improved cardiovascular and thermoregulatory responses (4). It could be that 
the prolonged moderate-intensity exercise of a TTE protocol could produce a metabolic 
environment in which these factors contribute more directly to fatigue (versus a time trial), thus 
increasing the likelihood that nutritional interventions, which impact these factors, would 
produce favorable results. However, this is highly speculative, as the mechanisms responsible for 
previously reported ergogenic effects with CP are poorly understood. In addition to the potential 
physiological differences between protocols, Hopkins and colleagues reported that time trial 
protocols may inherently introduce more error variance (due to differences in pacing), as 
compared to TTE protocols (6). Therefore, it is possible that the TTE protocol might be more 
sensitive in detecting small, but meaningful changes in performance compared to a TT protocol.  
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There are also a few limitations in the existing study which could have impacted our 
findings. The statistical power of our analyses was negatively affected by our small sample size, 
as only five subjects completed all exercise protocols (with a sixth completing all but the PRO 
trial). This decreases the confidence in our statistical conclusions. Furthermore, six additional 
subjects dropped out of the study prior to completion, likely due to the large number of 
demanding exercise trials (five three-hour trials over a month-long period, including the 
familiarization trial). This raises the concern that our subjects may have had difficulty 
maintaining consistent motivation and/or performance levels over the duration of the study. If so, 
this would also increase error variance and minimize the likelihood of detecting meaningful 
treatment effects. Therefore, further study is warranted in larger samples of competitive cyclists.   
As indicated previously, the potential mechanisms to explain performance gains with CP 
in prior studies (9, 14, 16) are not well understood.  Some have suggested that ergogenic effects 
are merely the result of additional calories from the supplemental protein (19, 20), while others 
have suggested that protein may have synergistic effects with carbohydrate when co-ingested (9, 
14, 16).  Therefore, a second purpose of our study was to determine if protein ingestion (PRO) 
alone affected cycling performance in comparison to a non-caloric placebo (PL).  To our 
knowledge, only one prior study has examined the potential ergogenic effects of protein 
consumed in isolation. Schroer and colleagues (2014) reported that protein ingestion resulted in 
possible performance impairments compared to placebo.  However, these investigators utilized a 
relatively high rate of protein ingestion (45 g/hr) in order to relate their findings to comparable 
ingestion rates of carbohydrate.  As a result, the possible impairments in performance with 
protein could have been due to gastrointestinal distress related to malabsorption of the relatively 
high doses of protein; a concept that was supported by increased incidents of GI discomfort with 
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protein versus placebo.  The present study was designed to examine a lower dose of protein 
ingestion (15 g/hr), which is directly comparable to the supplemental doses of protein provided 
in prior studies reporting ergogenic effects with CP co-ingestion (9, 14, 16).  This rate of 
ingestion was effective at minimizing gastrointestinal distress, as there was no evidence of 
increased gastrointestinal symptoms with PRO, and symptoms were low across all trials.  
However, PRO ingestion produced no clear benefits in performance (-0.6 ± 1.9 min) versus PL. 
This provides additional evidence that protein ingestion in isolation has no ergogenic effects; and 
thus, the previously reported benefits of CP beverages in some studies (9, 14, 16) were possibly 
the result of synergistic effects with carbohydrate. However, as mentioned previously, these 
conclusions should be interpreted cautiously due to the low statistical power in the present study. 
In summary, co-ingestion of carbohydrate and protein at moderate intake rates (45 
gCHO/hr + 15 gPro/hr) had no effect on cycling time-trial performance versus carbohydrate 
alone (45 g/hr).  In addition, protein intake alone (15 g/hr) had no ergogenic effects versus a non-
caloric placebo.  However, further study of this topic is required, as the present study lacked the 
statistical power to detect small but athletically-relevant differences in performance between 
treatments.   
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